Skip to Main content Skip to Navigation
Journal articles

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.

Résumé : To compare the efficacy and safety of subcutaneous (SC) and intravenous (IV) abatacept.
Document type :
Journal articles
Complete list of metadatas

https://hal.univ-brest.fr/hal-01557664
Contributor : Ghislaine Calvez <>
Submitted on : Thursday, July 6, 2017 - 2:11:17 PM
Last modification on : Thursday, March 12, 2020 - 2:24:01 PM

Identifiers

  • HAL Id : hal-01557664, version 1
  • PUBMED : 21618201

Collections

Citation

C. Genovese, A. Covarrubias, G Leon, E Mysler, M Keiserman, et al.. Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.. Arthritis and Rheumatism, Wiley, 2011, 63 (10), pp.2854-64. ⟨hal-01557664⟩

Share

Metrics

Record views

119